Lipogems International

Lipogems International is a medical technology company specializing in the processing of adipose tissue for regenerative medicine applications. The company's core technology is a closed-loop, FDA-cleared device that micro-fragments fat tissue while preserving the natural vascular-stromal niche, including mesenchymal stem cells and pericytes. This processed tissue is used as an injectable autologous graft to support tissue repair and healing in orthopedic, surgical, and wound care settings. Lipogems is widely utilized in treating joint pain, osteoarthritis, and complex fistulas, offering a minimally invasive alternative to more aggressive surgical interventions. The company is currently advancing clinical evidence through large-scale studies, such as the ARISE trials, to expand its regulatory clearances and standard-of-care status.